A higher level of CD44 expression was observed in 42% of PCa, 57% of HGPIN, and 42% BPH tissues, suggesting that CD44 expression was not correlated to malignant stage of prostate cancer [73]. This evidence concerns the gene CD44 and prostate cancer.